| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,470 |
44,408 |
$10.76M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,459 |
15,811 |
$4.91M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,775 |
27,705 |
$4.67M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,740 |
10,770 |
$1.45M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14,747 |
13,369 |
$885K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,451 |
14,565 |
$830K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,744 |
15,223 |
$610K |
| 71045 |
Radiologic examination, chest; single view |
13,745 |
12,417 |
$580K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,398 |
12,938 |
$403K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,905 |
2,264 |
$306K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,678 |
7,166 |
$305K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,904 |
6,980 |
$302K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,292 |
3,012 |
$263K |
| 80053 |
Comprehensive metabolic panel |
35,802 |
31,053 |
$249K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,548 |
2,287 |
$210K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,952 |
30,156 |
$180K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,035 |
918 |
$168K |
| 81025 |
|
17,478 |
15,895 |
$124K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
439 |
384 |
$117K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
714 |
676 |
$117K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,599 |
1,464 |
$113K |
| G0378 |
Hospital observation service, per hour |
689 |
342 |
$112K |
| 83880 |
|
5,064 |
4,580 |
$112K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,441 |
6,823 |
$100K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
316 |
239 |
$87K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,231 |
1,083 |
$86K |
| 84484 |
|
9,395 |
7,438 |
$68K |
| 80061 |
Lipid panel |
6,253 |
5,784 |
$61K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
519 |
404 |
$59K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,239 |
1,064 |
$46K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,413 |
10,163 |
$39K |
| 83690 |
|
7,125 |
6,388 |
$34K |
| 81001 |
|
14,557 |
13,031 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
793 |
714 |
$32K |
| 36415 |
Collection of venous blood by venipuncture |
15,288 |
12,993 |
$31K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,064 |
300 |
$29K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
361 |
293 |
$28K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,917 |
3,618 |
$26K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,171 |
1,080 |
$25K |
| 87400 |
|
1,755 |
790 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,963 |
1,797 |
$21K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
62 |
52 |
$20K |
| 80050 |
General health panel |
625 |
560 |
$19K |
| 73630 |
|
594 |
526 |
$19K |
| 81003 |
|
10,036 |
9,017 |
$16K |
| 93017 |
|
90 |
83 |
$14K |
| 80305 |
|
1,361 |
1,237 |
$13K |
| 82607 |
|
983 |
921 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,227 |
3,755 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,467 |
1,287 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,824 |
1,629 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
329 |
306 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
329 |
306 |
$10K |
| 84439 |
|
1,433 |
1,341 |
$10K |
| 73564 |
|
121 |
117 |
$9K |
| 73562 |
|
295 |
273 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
151 |
147 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,145 |
3,608 |
$7K |
| 87081 |
|
1,138 |
1,066 |
$7K |
| 82962 |
|
2,288 |
1,935 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
48 |
46 |
$5K |
| 93225 |
|
101 |
77 |
$5K |
| 80074 |
|
149 |
133 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
557 |
487 |
$5K |
| 83735 |
|
1,095 |
979 |
$5K |
| 74018 |
|
97 |
89 |
$4K |
| 87040 |
|
702 |
321 |
$4K |
| 96376 |
|
102 |
53 |
$4K |
| 72100 |
|
112 |
101 |
$4K |
| 86703 |
|
370 |
331 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
207 |
195 |
$4K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
18 |
13 |
$4K |
| 83605 |
|
527 |
420 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
167 |
54 |
$3K |
| 93226 |
|
101 |
77 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,298 |
1,129 |
$3K |
| 87807 |
|
251 |
223 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
947 |
833 |
$3K |
| 86803 |
|
219 |
203 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,032 |
897 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
301 |
280 |
$2K |
| 82043 |
|
408 |
382 |
$2K |
| 94060 |
|
14 |
14 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,282 |
1,127 |
$2K |
| 82570 |
|
433 |
407 |
$2K |
| 86140 |
|
485 |
426 |
$2K |
| 85027 |
|
345 |
321 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
34 |
32 |
$1K |
| 73610 |
|
51 |
42 |
$1K |
| 85610 |
|
634 |
561 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
113 |
101 |
$1K |
| 73130 |
|
43 |
41 |
$1K |
| 94726 |
|
14 |
14 |
$1K |
| 86038 |
|
133 |
114 |
$1K |
| 82550 |
|
245 |
227 |
$1K |
| 73030 |
|
41 |
38 |
$848.63 |
| 72040 |
|
13 |
12 |
$846.36 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
31 |
12 |
$757.16 |
| 94729 |
|
14 |
14 |
$712.62 |
| J1790 |
Injection, droperidol, up to 5 mg |
218 |
196 |
$677.19 |
| 84550 |
|
201 |
175 |
$632.80 |
| 84153 |
|
43 |
40 |
$606.87 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
19 |
17 |
$596.53 |
| 86592 |
|
170 |
148 |
$552.15 |
| 85379 |
|
87 |
77 |
$539.93 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
58 |
55 |
$493.76 |
| 84436 |
|
96 |
88 |
$473.76 |
| 87210 |
|
98 |
86 |
$435.75 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
12 |
12 |
$429.36 |
| 83970 |
|
15 |
12 |
$412.80 |
| 73560 |
|
17 |
17 |
$383.76 |
| 87186 |
|
74 |
66 |
$378.67 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
12 |
$372.84 |
| 86431 |
|
97 |
85 |
$370.58 |
| 85651 |
|
122 |
105 |
$361.60 |
| 87077 |
|
75 |
66 |
$353.67 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
82 |
48 |
$349.26 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
129 |
110 |
$307.69 |
| J1630 |
Injection, haloperidol, up to 5 mg |
119 |
106 |
$288.48 |
| 82553 |
|
31 |
27 |
$259.03 |
| J2060 |
Injection, lorazepam, 2 mg |
125 |
104 |
$226.14 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
13 |
13 |
$203.69 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
55 |
39 |
$180.53 |
| 86340 |
|
19 |
14 |
$165.88 |
| 80320 |
|
17 |
16 |
$156.00 |
| 82746 |
|
12 |
12 |
$147.00 |
| 85730 |
|
40 |
37 |
$144.24 |
| 82728 |
|
15 |
13 |
$136.30 |
| 84466 |
|
12 |
12 |
$127.60 |
| 82150 |
|
33 |
26 |
$124.80 |
| 36000 |
|
13 |
13 |
$99.72 |
| 87088 |
|
14 |
13 |
$64.72 |
| 83540 |
|
12 |
12 |
$64.70 |
| J1940 |
Injection, furosemide, up to 20 mg |
14 |
12 |
$42.46 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
32 |
24 |
$39.90 |
| 84156 |
|
13 |
12 |
$22.02 |
| J2704 |
Injection, propofol, 10 mg |
1,393 |
1,045 |
$20.04 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
12 |
$19.27 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
53 |
40 |
$19.17 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
55 |
41 |
$9.45 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
127 |
106 |
$8.61 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
37 |
25 |
$7.97 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
154 |
113 |
$2.92 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
51 |
37 |
$0.00 |
| 00811 |
|
32 |
31 |
$0.00 |
| 00731 |
|
115 |
101 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
51 |
43 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
150 |
127 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
535 |
338 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
13 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
12 |
$0.00 |